Contributors


Jordyn Sava

Latest:

Padcev Plus Keytruda Shows Promise for Upper Tract Urothelial Carcinoma Lesions

Results from a small retrospective analysis of patients with upper tract urothelial carcinoma lesions were shared at the 2025 ASCO Genitourinary Cancers Symposium.


Stephanie Loder

Latest:

‘Coming Out’ to Cancer: LGBTQIA+ Discrimination in the Health Care System

Fear of facing discriminatory behavior within the health care system, along with other factors, may keep members of the LGBTQIA+ community from receiving cancer diagnoses.


Linda McMillan

Latest:

Treating the Whole Patient Rather Than Just Cancer Issues

A patient details the compassionate support that she received from an oncology nurse while receiving back-to-back treatments for cancer.


John Walker

Latest:

Building Bridges of Inclusion in Metastatic Breast Cancer Care

A man describes his wife’s tireless efforts to advocate for people of color in the metastatic breast cancer field, where many still face disparities within care, inclusion in clinical trials and survival outcomes.


City of Hope

Latest:

Renowned Breast Cancer Physician-Scientist Dr. Hope S. Rugo to Lead City of Hope’s Women’s Cancers Program

Dr. Rugo has led key breast cancer therapy trials and exudes a passion for serving patients.


Patricia Buls

Latest:

Getting Through Grief Caused By Cancer

When experiencing loss, always look forward and have hope.


Christina Passio, MSN, RN, NE-BC

Latest:

Nurse Champions of Patient Safety, Dignity and Leadership

Three nurses—Maria Hicinbothem, Wandaris Ortiz, and Sandi Wetherbee—are being celebrated for their exceptional dedication to patient care, safety and advocacy.


Jax DiEugenio

Latest:

Subcutaneous Opdivo Similarly Effective, Safe as IV for Advanced ccRCC

Subcutaneous Opdivo showed comparable effectiveness, safety and tolerability to IV Opdivo in advanced clear cell renal cell carcinoma.


Dr. Catherine Wu

Latest:

Personalized Cancer Vaccine Demonstrates Responses in Kidney Cancer

Dr. Catherine Wu discussed the unique aspects of clear cell renal cell carcinoma and the challenges of targeting it with a vaccine.


Maureen Murphy Chodaba

Latest:

Perhaps a Pearl: An Experience That Led to Meeting Another Breast Cancer Survivor

A woman dedicates a poem to the experience of meeting a fellow breast cancer survivor.


Jill Feldman

Latest:

The Power of Unity: Why the Lung Cancer Genetics Study Matters

The Lung Cancer Genetics Study, a collaboration between lung cancer advocacy organizations, aims to explore the genetics of lung cancer


Melinda Bachini

Latest:

From Patient 3737 to Advocate: The Life-Changing Power of Clinical Trials

Melinda Bachini is the Chief Patient Officer at the Cholangiocarcinoma Foundation and a 15-year survivor of cholangiocarcinoma.


Darlene Burns

Latest:

Achieving a Childhood Dream by Caring for Patients With Cancer

From her earliest childhood days, Tammy Allred, RN, OCN, had a vision for her future: to soothe and to heal.


Marc Kurnick

Latest:

Cancer’s Visit

It’s been a long road since being diagnosed with melanoma in early 2020.


Catherine Kanjer Kapphahn

Latest:

The Waiting Room

A father and daughter spend 39 mornings in radiation oncology.



Dr. Eric Jonasch

Latest:

MK-6482 Shows Promise in von Hippel-Lindau Disease-Associated Renal Cell Carcinoma

The HIF-2a Inhibitor induced clinical responses among patients with von Hippel-Lindau disease–associated kidney cancer, according to results presented at the 2020 ASCO Virtual Scientific Program.



MELISSA A. GRIER

Latest:

Summer and Skin Cancer: Staying Safe in the Sun

While the summer months are the perfect time for outdoor activities with friends and family, it is crucial to protect yourself from skin cancer.


Gregory Caroll

Latest:

Cancer Care Is a Matter of Opinions

Looking back in 2018, I am so glad that we sought out the other opinions. Nerve wracking as it was, the process opened up other options we would not have known about.


William Ramshaw

Latest:

What I Do When My Doctors Don’t Listen

Here are four signs of your doctor not listening and four things I do when they don't listen to me.


Lori A. Leslie, MD

Latest:

Future Directions in CLL Treatment

Lori A. Leslie, MD, and Hoshiyuki Iida, APN, offer closing thoughts on the future treatment landscape of chronic lymphocytic leukemia.


Noelle Paul

Latest:

Making a Difference: An Interview with Noelle Paul, RN, BSN, OCN, CAPA

Noelle Paul has time to talk on the way home from her job as an oncology surgical nurse at Memorial Sloan Kettering Cancer Center in New York City.


Jitsuda Sitthi-Amorn, M.D., St. Jude Children

Latest:

In the Hands of an Angel

An Extraordinary Healer article honoring LAUREN H. McMURRY, B.S.N., RN [ST. JUDE CHILDREN’S RESEARCH HOSPITAL, MEMPHIS, TENNESSEE]


Elizabeth Swisher, M.D.

Latest:

Elizabeth Swisher Discusses Rucaparib's Side Effects for Patients With Ovarian Cancer

Elizabeth Swisher, M.D., professor, Department of Medicine, Division of Medical Genetics, University of Washington School of Medicine, Breast and Ovarian Cancer Prevention Program, Seattle Cancer Care Alliance, discusses the side effects of rucaparib in the ARIEL2 trial, for patients with relapsed, platinum-sensitive high-grade ovarian carcinoma.


Nicole Scobie

Latest:

The Waiting Room

A kid can bring out the best in people.


C. Ola Landgren

Latest:

Diagnosing and Treating Smoldering Multiple Myeloma

C. Ola Landgren provides an overview of the diagnosis and treatment of smoldering multiple myeloma.


Deborah Bell

Latest:

Supporting Teens and Young Adults Through Cancer

Specialized hospital programs — with help from "The Who" rockers — support teens and young adults through cancer.


Lynne S. Nemeth, Ph.D., RN, FAAN

Latest:

Treating the Whole Patient

"Her goal is to improve the cancer experience and management of cancer as a chronic disease, extending those efforts into survivorship."


Mary K. Caffrey

Latest:

Through Partnership, Pancreatic Cancer Patients Gain Access to Personal Treatment Options

A partnership between the Pancreatic Cancer Action Network and Perthera, a self-described "concierge" for molecular diagnostic testing, is giving patients with this hard-to-treat cancer the ability to determine the best course of treatment.